Patent · US Expired

Peptide-containing liposomes, immunogenic liposomes and methods of preparation and use

US5916588A · kind A · utility

50Cited by
29References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 25, 1995
Grant dateJun 29, 1999
Priority date
Expiry dateMay 25, 2015

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2039/55555
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A high integrity liposome comprising at least one stabile lipid and at least one peptide-like therapeutic agent associated with the liposome, adapted for parenteral administration to an animal, including a human, and method according to manufacture and use. Immunizing dosage forms comprising a liposome and an immunogen, wherein the liposome and immunogen are present in an immunization dose. Additionally, a dosage form, including such form particularly adapted to producing an immune response, comprising a salt according to an organic acid derivative of a sterol and an immunogen are present in an immunization dose, and method according to uses is disclosed. Further, a dosage form, including such form particularly adapted to producing an immune response, comprising dimyristolyphosphatidylcholine (DMPC)/cholesterol liposomes, optionally in an aluminum hydroxide gel, and an immunogen wherein the DMPC/cholesterol and immunogen are present in an immunization dose, and method according to use.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.